Menu Search
Equities

VentriPoint Diagnostics Ltd

5V7:BER

VentriPoint Diagnostics Ltd

Actions
  • Price (EUR)0.094
  • Today's Change-0.002 / -2.08%
  • Shares traded--
  • 1 Year change-2.08%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024 08:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year VentriPoint Diagnostics Ltd had revenues fall -27.86% from 68.17k to 49.18k, though the company grew net income from a loss of 4.87m to a smaller loss of 4.87m.
Gross margin48.08%
Net profit margin-6,965.84%
Operating margin-6,915.71%
Return on assets-220.33%
Return on equity-2,972.60%
Return on investment-562.35%
More ▼

Cash flow in CADView more

In 2023, cash reserves at VentriPoint Diagnostics Ltd fell by 3.89m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 3.80m for operations while cash used for investing totalled .
Cash flow per share-0.0316
Price/Cash flow per share--
Book value per share-0.0131
Tangible book value per share-0.0131
More ▼

Balance sheet in CADView more

VentriPoint Diagnostics Ltd uses little or no debt in its capital structure.
Current ratio0.2839
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.